Carna Health
Olivier Tak is a multidisciplinary professional with a focus on life sciences and healthcare investment. Currently serving as a Junior Partner at Curie Capital BV since August 2022, Olivier also advises at Carna Health and holds a position as a Visiting Researcher in Neuroimmunology at Harvard Medical School. Previous experience includes roles as an Investment Banking Intern at Kempen & Co, a Visiting Student at The Francis Crick Institute, and an Investment Analyst at Curie Capital BV during its early establishment. Earlier positions include a Life Science Investment Analyst at De Groot Family Office and a Summer Intern at medicxi. Educational qualifications encompass a Master of Science in Medicine from Erasmus University Rotterdam and a Bachelor of Science in Nanobiology from Delft University of Technology, alongside ongoing Bachelor of Science studies in Medicine at Erasmus University Rotterdam.
This person is not in any teams
Carna Health
Our goal is to disrupt the trajectory of end-stage kidney disease through integrated digital health screening, monitoring of disease progression, and predictive analytics that enable decision-support opportunities.